CIK 0001628171
- Large accelerated filer
Revolution Medicines, Inc.
Sign in to watch- Ticker
- RVMD
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 472029180
- Phone
- +1 650-481-6801
- Business address
- 700 SAGINAW DR, REDWOOD CITY, CA, 94063
Securities
- RVMD Common Stock Nasdaq
- RVMDW Warrant Nasdaq
- 4 Grant or award Chief Financial Officer acquired 20,200 shares (grant or award)
- 4 Exercise or conversion GOLDSMITH MARK A acquired 24,010 shares (option exercise)
- 4 Planned sale General Counsel sold 908 shares at $115.60 ($104,965)
- 4 Planned sale Chief Operating Officer sold 75,000 shares at an average $100.56 ($7,542,023)
- 4 Planned sale Chief Financial Officer sold 10,000 shares at $98.00 ($980,000)
- 4 Planned sale General Counsel sold 2,688 shares at $76.82 ($206,484)
- 4 Planned sale GOLDSMITH MARK A sold 15,394 shares at $76.82 ($1,182,526)
- 4 Planned sale Kelsey Stephen Michael sold 5,447 shares at $76.82 ($418,423)
- 4 Planned sale Chief Operating Officer sold 4,847 shares at $76.82 ($372,333)
- 4 Planned sale Chief Financial Officer sold 3,104 shares at $77.09 ($239,289)
- 4 Planned sale Chief Financial Officer sold 5,418 shares at $74.00 ($400,932)
- 4 Planned sale GOLDSMITH MARK A sold 66,000 shares at an average $75.08 ($4,954,962)
- 4 Planned sale GOLDSMITH MARK A sold 20,000 shares at $70.38 ($1,407,586)
- 4 Planned sale General Counsel sold 13,388 shares at $70.14 ($939,008)
- 4 Planned sale GOLDSMITH MARK A sold 20,000 shares at $65.07 ($1,301,410)
- 4 Planned sale Chief Financial Officer sold 10,000 shares at $64.00 ($640,000)
- 4 Planned sale GOLDSMITH MARK A sold 30,000 shares at $60.31 ($1,809,306)
- 4 Planned sale General Counsel sold 12,000 shares at $55.00 ($660,000)
- 4 Planned sale GOLDSMITH MARK A sold 20,000 shares at an average $52.74 ($1,054,701)
- 4 Planned sale Kelsey Stephen Michael sold 25,000 shares at $48.54 ($1,213,540)
Page 4 of 21 · 414 filings